Results

Total Results: 3,080 records

Showing results for "drugs".

161. Development of a Multipurpose Dataset to Evaluate Potential Medication Errors in Ambulatory Settings (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol2/Chan.pdf
     July 01, 2004 - If a single health plan member had used multiple drugs of interest, that person would have multiple … For patients with multiple diseases and receiving several drugs, the analytic datasets would include … only the drugs, diseases, and/or laboratory tests of interest. … The Chronic Disease Score, a metric based on outpatient utilization of drugs for chronic diseases to … (The drugs were selected in the revised Beers criteria as potentially inappropriate for persons age

162. Data Visualizations | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/data-visualization/index.html?page=1
     September 01, 2023 - Hospitalizations Influenza Injuries Mental Disorders Mental Health Nursing Homes Opioids Poverty Prescription Drugs

163. Data Infographics | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/infographics/index.html
     February 01, 2025 - Illicit Drug Use Treatment In-Hospital Mortality Rates Related to Diabetes Hospitalizations for Diabetes Drugs … Visits Related to Flu and Flu-like Illnesses, by Age Group Reduced Median Annual Spending for Retail Drugs

164. AHRQ Research Inspires Efforts at Banner Desert To Reduce Drug Errors in E.D. Patients | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsroom/case-studies/201509.html
     January 01, 2018 - The technicians interview these patients to learn what drugs, vitamins, and supplements they take, as … "Many times, we see patients taking multiple drugs for the same condition, which may or may not be

165. 6 Tk1 T3-Resident Information Sheet Antibiotic-Resistant Bacteria Final (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/nhguide/6_TK1_T3-Resident_Information_Sheet_Antibiotic-Resistant_Bacteria_Final.docx
     October 01, 2016 - Antibiotics are drugs that kill bacteria that cause infections. … www.cdc.gov/drugresistance/about.html FDA: Antibiotics and Antibiotic Resistance http://www.fda.gov/Drugs

166. Sepsis in the ED Detailed Measure, Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-228-detailed_measure-specs.pdf
     August 01, 2014 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β-blocker drugs

167. Data Visualizations | Agency for Healthcare Research and Quality
     www.ahrq.gov/data/visualizations/index.html
     May 01, 2023 - Antidepressant Use and Expenses in the United States Between 2013 and 2018 Retail and Mail Order Drugs

168. Final Progress Report: Improving Patient Safety by Reducing Medication Errors (pdf file)
     www.ahrq.gov/sites/default/files/2024-03/strom2-report.pdf
     January 01, 2024 - users of drugs … the leading drugs causing serious dose-related ADEs. … We identified both new and chronic users of drugs at the time prescriptions are filled. … Nephrotoxic drugs have been identified as a major cause of ARF. … understanding, new systems can be developed and existing ones modified to enhance the safety of pharmaceuticals

169. Final Progress Report: Do Safety Warnings Change Prescribing Among the US Dialysis Population? (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/research/findings/final-reports/20572-Thamer-draft-1.pdf
     January 01, 2013 - (FDA) outlining new safety information about erythropoiesis- stimulating agents (ESAs), widely used drugs … Conversely, use of other intravenous drugs continued to increase in 2008: 12% for IV vitamin D, 4.8% … [http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088591.pdf] 29. … http://www.usrds.org/adr.htm http://www.fda.gov/downloads/Drugs/DrugSafety/ucm088591.pdf Principal … Office of Inspector General: Medicare Reimbursement for Existing End-stage Renal Disease Drugs.

170. Outpatient Benzodiazepine Prescribing, Adverse Events, and Costs (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/French.pdf
     April 27, 2004 - Fall-contributing adverse effects of the most frequently prescribed drugs. … Drugs and falls in later life. Lancet 2003 Feb 8;361(9356):448. 7. … Drugs and falls in older people: a systematic review and meta- analysis: I psychotropic drugs. … Drugs and falls in older people: a systematic review and meta- analysis: II cardiac and analgesic drugs … Drugs & Aging 1998 Jan;12(1):43–53. 25. Koski K, Luukinen H, Laippala P, et al.

171. Strategy 6N: Price Transparency | Agency for Healthcare Research and Quality
     www.ahrq.gov/cahps/quality-improvement/improvement-guide/6-strategies-for-improving/access/strategy6n-price-transparency.html
     March 01, 2020 - have the time to explore alternatives (e.g., maternity care, elective surgeries); and prescription drugs … Payment Data , which summarizes utilization and payments for procedures, services, and prescription drugs … total costs for the procedure, where total cost includes physician services, facility fees, anesthesia, drugs

172. AHRQ Views Blog: Agency Support for Telementoring Boosts Battle Against COVID-19 | Agency for Healthcare Research and Quality
     www.ahrq.gov/news/newsletters/e-newsletter/720.html
     July 01, 2020 - When Taking Warfarin With NSAIDs Patients who take both warfarin and nonsteroidal anti-inflammatory drugs … 11 studies, published between 1993 and 2013, to evaluate bleeding risks associated with these common drugs

173. ADHD Behavior Therapy References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-89-adhd-behavior-references.pdf
     August 12, 2012 - Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention- deficit/hyperactivity disorder.

174. References (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/policymakers/chipra/factsheets/fullreports/chipra-88-references.pdf
     August 12, 2012 - Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Hallucinations and other psychotic symptoms associated with the use of attention-deficit/hyperactivity disorder drugs … Cardiovascular monitoring and stimulant drugs for attention- deficit/hyperactivity disorder.

175. Quantitative and Qualitative Analysis of Medication Errors: The New York Experience (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/professionals/quality-patient-safety/patient-safety-resources/resources/advances-in-patient-safety/vol1/Duthie.pdf
     January 01, 2004 - A review of medication classes involved revealed the most common classes to be cardiovascular drugs … In other cases, providers omitted drugs that patients were already taking in the transition across levels … involved in the error will prevent an error with that drug, but not prevent occurrences with other drugs … Each organization would need to identify all high-risk drugs contained in the off-hour cabinet/supply … Orders for drugs with only one indication or dosing regimen would not need to carry the indication

176. Rapid Secondary Analysis to Optimize Care for Patients with Multiple Chronic Conditions (R01) | Agency for Healthcare Research and Quality
     www.ahrq.gov/prevention/chronic-care/decision/mcc/secondary-analysis-hs14001.html
     September 01, 2015 - Vaughan Sarrazin, University of Iowa Novel Role for Adiponectin-enhancing Drugs for Asthma in the Obese

177. Final Progress Report: Electronic Communications Across Provider Settings (pdf file)
     www.ahrq.gov/sites/default/files/2024-07/morrison-report.pdf
     January 01, 2024 - Step 2: From these reports, tease out the “high-risk” drugs and drugs for which there is evidence- based … Step 3: Once the “high-risk” drugs are identified, develop reports that look at patients who are on … each of these drugs and meet one or more of the following: o Patient has presented with A, B symptoms

178. Appendix K. Final Risk Factors | Agency for Healthcare Research and Quality
     www.ahrq.gov/research/findings/final-reports/ssi/ssiapk.html
     April 01, 2018 - Staph Aureus Colonization 3 2 0 Preoperative Shower 4 3 0 Immunosuppressive Drugs … Injections into Wound (e.g., Local Anesthetic) 0 1 0 Implant 3 3 0 Anesthetic Drugs

179. Section 2, Technical Specifications (pdf file)
     www.ahrq.gov/sites/default/files/wysiwyg/pqmp/measures/acute/chipra-229-section-2-tech-specs.pdf
     February 09, 2018 - defined as a mean heart rate > 2 SD above normal for age in the absence of external stimulus, chronic drugs … as a mean heart rate <10th percentile for age in the absence of external vagal stimulus, β- blocker drugs

180. Release-Medical-Info (doc file)
     www.ahrq.gov/sites/default/files/wysiwyg/health-literacy/3rd-edition-toolkit/release-medical-info.docx
     March 01, 2024 - My use of drugs or alcohol.